If you’ve been following mental health research lately, you may have come across the term metabolic psychiatry. It’s one of the fastest-growing areas in psychiatry — and it’s challenging some of the most entrenched assumptions about how we treat mental illness.
At its core, metabolic psychiatry asks a simple but radical question: what if many mental health conditions are, at least in part, disorders of brain energy metabolism?
The Core Idea
The brain is extraordinarily energy-hungry. It accounts for roughly 2% of body weight but consumes about 20% of total energy. When the mechanisms that supply that energy — mitochondrial function, glucose utilisation, ketone metabolism — go wrong, brain function suffers in ways that can look exactly like depression, anxiety, bipolar disorder, or schizophrenia.
Metabolic psychiatry proposes that:
- Mitochondrial dysfunction may underlie a range of psychiatric conditions
- Neuroinflammation — closely linked to metabolic disruption — alters neurotransmitter balance
- Dietary interventions that improve metabolic health may directly improve mental health
The Role of the Ketogenic Diet
The ketogenic diet (very low carb, high fat) has been used for nearly a century to treat drug-resistant epilepsy — a neurological condition. Metabolic psychiatry researchers began asking: if keto can stabilise abnormal electrical activity in the brain, what might it do for mood and psychosis?
Several mechanisms have been proposed:
- Ketone bodies as cleaner fuel — beta-hydroxybutyrate and acetoacetate bypass impaired glucose metabolism and provide neurons with an efficient alternative energy source
- Glutamate/GABA rebalancing — keto appears to increase GABA (calming) relative to glutamate (excitatory), reducing neuronal overfiring
- Anti-inflammatory effects — the ketogenic diet has documented anti-inflammatory properties that may reduce neuroinflammation implicated in depression and psychosis
- Mitochondrial biogenesis — ketosis appears to stimulate the growth of new, healthier mitochondria
The Research Landscape
As of 2025, the UKRI Hub for Metabolic Psychiatry coordinates more than 20 clinical trials worldwide investigating ketogenic diets in psychiatric populations. Individual studies have examined:
- Bipolar disorder — Dr. Iain Campbell’s pilot RCT at the University of Edinburgh (27 patients, MRS neuroimaging, 6–8 weeks) found reduced brain glutamate and improved mood stability on keto
- Schizophrenia — early case reports and small trials suggest improvements in psychotic symptoms and cognitive function
- Depression and anxiety — multiple observational studies show mood improvements with keto; mechanistic work points to GABA/glutamate normalisation and reduced neuroinflammation
- Treatment-resistant conditions — perhaps the most exciting frontier, with some patients reporting remission after years of medication failures
The Gut–Brain Connection
For those interested in digestive health, the link between the gut microbiome and mental health is particularly relevant here. The ketogenic diet dramatically alters the gut microbiome composition — reducing populations of carbohydrate-fermenting bacteria and potentially increasing short-chain fatty acid producers that support the gut-brain axis.
Some researchers believe that part of keto’s psychiatric benefit is mediated through the gut: changes to the microbiome that reduce intestinal permeability (leaky gut), lower systemic inflammation, and improve vagal nerve signalling to the brain.
Who Is Leading This Field?
The name you’ll encounter most often is Dr. Christopher Palmer, a Harvard psychiatrist and researcher who has spent over two decades studying metabolic interventions in psychiatry. His book Brain Energy is widely considered the definitive lay-accessible overview of the field. He argues — with compelling case studies and mechanistic evidence — that mental illnesses are metabolic disorders and that the ketogenic diet may be among the most powerful interventions available.
Other key figures include Dr. Georgia Ede, Dr. Iain Campbell, and the team at Stanford running the Metabolic Psychiatry Clinic.
Is This Ready for Clinical Practice?
Not yet — at least not as a first-line treatment. The evidence base is growing rapidly, but most studies to date are small, short-term, or observational. Larger, longer, randomised controlled trials are underway and needed before metabolic psychiatry can become standard practice.
That said, for people who have tried multiple medications without adequate relief, the risk-benefit calculation may already favour trying a supervised ketogenic diet alongside conventional treatment. Several metabolic psychiatry clinics now exist that offer exactly this kind of integrated approach.